Actinomycin D belongs to the class of polypeptide antibiotics and is isolated from bacteria of the genus Streptomyces. Actinomycin D acts by interfering with mRNA synthesis. Actinomycin D is used as a selective antibiotic for resistant bacteria, generally at a concentration of about 1 µg/ml. This product is provided as a powder and should be made into a stock solution at 1 mg/ml in DMSO. We also offer a variety of cell culture antibiotics.
Product Use For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.
cGMP Manufacturing Gibco® Actimonmycin D is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.